2179.HK · RECBIO-B
Hong Kong · RS rating 28 · As of 2026-11-03
| Price | 4.00 HKD |
|---|---|
| 1-day change | +0.0% |
| RS rating (overall / 1M / 3M / 12M) | 28 / 39 / 25 / 25 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 18 / 5 / 8 |
| Industry group (rank) | Pharma & Biotech (27) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +43.7% |
| Market cap (USD) | $319.2M |